Angiotech Pharmaceuticals, Inc. Release: Notice Of Conference Call And Webcast

VANCOUVER, Jan. 25 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2006.

Thursday, February 1, 2007 at 4:30 PM (EST) (1:30 PM Pacific, 2:30 PM Mountain, 3:30 PM Central) Dial information is as follows: North America (toll-free): 1-800-561-2693 International: 1-617-614-3523 Enter passcode: 96122419

A live webcast will be available to all interested parties through Angiotech's website at www.angiotech.com under the Investors Relations section.

A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 4:00 PM EST (1:00 PM Pacific, 2:00 PM Mountain, 3:00 PM Central).

A replay archive of the conference call will be available until February 8, 2007.

Replay archive information is as follows: North America: 1-888-286-8010 International: 1-617-801-6888 Enter passcode: 30636547 About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with 17 facilities in 6 countries and over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech , please visit our website at www.angiotech.com.

CONTACT: Analysts, Institutional, and Retail Investors: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com; Media: Jodi Regts, Manager, Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, jregts@angio.com

Angiotech Pharmaceuticals, Inc.

CONTACT: Analysts, Institutional, and Retail Investors: Deirdre Neary,Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604)222-7056, dneary@angio.com; Media: Jodi Regts, Manager, CorporateCommunications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,jregts@angio.com

MORE ON THIS TOPIC